Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 40Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 18Rectal Neoplasms 14Lung Neoplasms 13Stomach Neoplasms 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Esophageal Squamous Cell Carcinoma 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Adenocarcinoma Of Esophagus 8Sarcoma 7Ovarian Neoplasms 7Neoplasms 6Head and Neck Neoplasms 6Urinary Bladder Neoplasms 5Osteosarcoma 5Liver Neoplasms 5Kidney Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Turcot syndrome 3Multiple Myeloma 3Locally Advanced Rectal Cancer 3

Interventions

Carboplatin 36Pemetrexed 28Bevacizumab 26Cisplatin 24Paclitaxel 22Gemcitabine 20Radiotherapy 18Docetaxel 18Erlotinib Hydrochloride 15Gefitinib 11pembrolizumab 6Cetuximab 6capmatinib 5Surgical Procedures, Operative 5Radiosurgery 5aflutinib 4Vinorelbine 4Taxes 4Platinum 4Nivolumab 4Metformin 4pegfilgrastim 3durvalumab 3ceritinib 3apatinib 3Sorafenib 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3tislelizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma of Lung × Neoadjuvant Therapy × Clear all
NCT02980991 2023-07-20

Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)

Fudan University

Phase 2 Completed
80 enrolled
Thoracic

Adenocarcinoma of Lung

NCT00398385 2013-08-12

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
170 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00616499 2009-02-09

Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡